ICCM 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference and Expo on Clinical Microbiology” (ICCM 2023) Hybrid Event scheduled during June 23-24, 2023 | Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at clinical-microbiology@magnusconference.com or call +1 (702) 988 2320.
2nd Edition of International Conference
and Expo on Clinical Microbiology
June 23-24, 2023 | Rome, Italy
International Conference and Expo on
Clinical Microbiology
Event Book
Event program
Scientific Program
About
Magnus Group hosted its annual flagship event "International Conference and Expo on Clinical Microbiology" (ICCM 2022) which was held virtually during June 17-18, 2022.
ICCM 2022 has been instrumental in bringing clinical microbiologists and experts together from all parts of the world. This international conference's main objective was to increase medical knowledge while fostering personal and professional networks. Due to the COVID-19 pandemic, it has been challenging for us to meet offline. Researchers, scientists, microbiologists, principal investigators, healthcare experts, and professors from academia and the healthcare sector, as well as business representatives, academicians, scholars, and students from all over the world, gathered for ICCM 2022 in order to present their research findings, fresh concepts, and hands-on development experiences in clinical microbiology. After the prodigious success of ICCM 2022, we truly believe that the congress has and will continue to mark a turning point for the reunion of scholars and colleagues in clinical microbiology.
Scientific Committee Members
Muhammad Morshed
University of British Columbia, Canada
AC Matin
Stanford University, United States
Giuseppina Mandalari
University of Messina, Italy
Jawad Alzeer
University of Zurich, SwitzerlandSpeakers
Adnan Alrubaye
University of Arkansas, United States
Iti Saraav
Washington University in St Louis, United States
Miguel Cruz
Mexican Social Security Institute., Mexico
Miguel Vazquez Moreno
Mexican Social Security Institute, Mexico
Adriano Alberti
Universidade do Sul de Santa Catarina, Brazil
Luana Lorena Silva Rodrigues
Federal University of Western Pará, Brazil
Anderson Rodrigues dos Santos
Federal University of Uberlândia, Brazil
Amira Awad Moawad
Federal Research Institute for Animal Health, Germany
Noha Tharwat Abou El Khier
Mansoura University, Egypt
Shikhar Tripathi
Sir Ganga Ram Hospital, India
Dimple Sethi Chopra
Punjabi University, India
Chandan Kumar
AIIMS, India
Vijay Prabha
Panjab University, India
Hem Chandra Jha
Indian Institute of Technology Indore, India
Jan Mohammad Mir
Islamic University of Science and Technology, India
Jayaweera Arachchige Asela Sampath Jayaweera
Rajarata University of Sri Lanka, Sri Lanka
Abderrahmen Merghni
University of Tunis El Manar, TunisiaGallery
Reviews
Title : CRISPR/Cas12a-powered ultrasensitive immunosensing for the detection of single microorganisms
Fei Deng, University of New South Wales, Australia
Title : Multidrug resistance in burn patients
Dimple Sethi Chopra, Punjabi University, India
Title : COVID 19 pandemic; a complex mixture of co-infection and comorbidity
Hem Chandra Jha, Indian Institute of Technology Indore, India
Title : Interpretation of non-responders to SARS CoV 2 vaccines using WHO International Standard
Xu Yang, Shanghai University of Medicine and Health Sciences, China
Title : Applications of Artificial Intelligence in Clinical Microbiology Diagnostic Testing
P Hema Prakash Kumari, GITAM Institute of Medical Sciences and Research, India
Title : O GlcNAcylation enhances sensitivity to RSL3 induced ferroptosis via the YAP TFRC pathway in liver cancer
Abduh Murshed, Tongji University, China